Study: New cholesterol drugs cost 356 times more than generics September 29, 2016 By Tracey Walker A report from the Alliance of Community Health Plans can help get a better sense of how well drugs help patients compared to other treatment options. Four reasons why a hospital should open an integrated pharmacy September 25, 2016 By Dana Fox When is retail right? Consider these four benefits that will impact the bottom line. HHS makes clinical trials more transparent September 23, 2016 By Tracey Walker HHS finalized ClinicalTrial.gov rules encourage healthcare improvement and public benefit by increasing transparency and accountability across the industry. Medicare Part D patients not taking blood pressure meds correctly September 20, 2016 By Tracey Walker Expert offers specific actions for managed care execs to take Integrated pharmacy model improves adherence, reduces costs September 12, 2016 By Tracey Walker Study shows that an integrated pharmacy approach with community mental health centers produces higher adherence rates and lower overall healthcare costs. Remicade will now have a biosimilar August 24, 2016 By Tracey Walker Expert: Expectations are high that biosimilars can control overall biologic cost growth. Four things executives need to know to combat rising drug spend Executives need to ask themselves four key questions to mitigate the negative impact of rising drug costs. Biosimilar drugs appear comparable to brand-name counterparts August 08, 2016 By Tracey Walker Systematic review provides comprehensive first look at TNF-alpha biosimilar treatments. Increased utilization driving pharmacy spend in exchange plans July 07, 2016 By Tracey Walker Express Scripts Exchange Pulse report found that utilization, particularly for traditional meds, was one of the biggest factors driving spending in 2015, accounting for more than half of the exchange plans $99 PMPY increase in spending between 2014 and 2015. Antibiotic stewardship programs: 4 case studies July 06, 2016 By Tracey Walker All antibiotic use has the potential to contribute to the development of antibiotic resistance. That’s why it is key to reduce inappropriate antibiotic use in order to slow the growth of resistance.